Interferon-gamma gene therapy (Chiron/Cell Genesys)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInterferon-gamma gene therapy (Chiron/Cell Genesys)
Drug Alias Name干扰素-γ基因疗法-Chiron/Cell Genesys
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionInterferon gamma receptor stimulantsImmunostimulants
TargetsInterferon gamma receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChironBiosante Pharmaceuticals IncNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A